The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
出版年份 2021 全文链接
标题
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
作者
关键词
-
出版物
NATURE MEDICINE
Volume 27, Issue 11, Pages 1954-1960
出版商
Springer Science and Business Media LLC
发表日期
2021-10-29
DOI
10.1038/s41591-021-01536-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial
- (2021) Michael E. Nassif et al. CIRCULATION
- Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
- (2021) Scott D. Solomon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction
- (2021) Ambarish Pandey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity
- (2020) Yogesh N.V. Reddy et al. EUROPEAN JOURNAL OF HEART FAILURE
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
- (2020) Yogesh N.V. Reddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
- (2020) William T Abraham et al. EUROPEAN HEART JOURNAL
- Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR‐Preserved Trial
- (2020) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Failure With Preserved Ejection Fraction In Perspective
- (2019) Marc A. Pfeffer et al. CIRCULATION RESEARCH
- Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
- (2019) Shannon M. Dunlay et al. CIRCULATION
- Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
- (2019) Alvin Chandra et al. JACC-Heart Failure
- Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
- (2019) Michael E. Nassif et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients’ Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms
- (2019) Shelby D. Reed et al. Circulation-Cardiovascular Interventions
- Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure
- (2019) Hideo Nambu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
- (2018) Sanjiv J Shah et al. EUROPEAN HEART JOURNAL
- Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction
- (2017) Emil Wolsk et al. EUROPEAN JOURNAL OF HEART FAILURE
- Epidemiology of heart failure with preserved ejection fraction
- (2017) Shannon M. Dunlay et al. Nature Reviews Cardiology
- B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction
- (2013) Dirk J. van Veldhuisen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started